SL
The startup develops a radio-labeled tracer technology for molecular imaging, specifically targeting the assessment of disease activity in inflammatory arthritis and endometriosis. This platform aims to enhance patient outcomes and quality of life while lowering healthcare costs for medical practitioners.
Updated 3 months ago
Funding
$20.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a radio-labeled tracer technology for molecular imaging, specifically targeting the assessment of disease activity in inflammatory arthritis and endometriosis. This platform aims to enhance patient outcomes and quality of life while lowering healthcare costs for medical practitioners.